Johnson & Johnson hit with $8B verdict over drug linked to boy growing breasts
There's more legal trouble for Johnson & Johnson. A Philadelphia jury has ordered it to pay $8 billion in punitive damages in a case unrelated to lawsuits over its signature baby powder. The jury found the company failed to warn a man taking the anti-psychotic drug, Risperdal, of its side effects. Anna Werner reports.